BETHESDA, Md., Oct. 27, 2015 /PRNewswire-USNewswire/ -- The Parenteral Drug Association (PDA) is once again hosting its Universe of Pre-Filled Syringes and Injection Devices conference in Europe. The November 3-4 event takes place in the Austria Center Vienna. This year, 103 vendors will be on hand to display their products and solutions for pharmaceutical companies looking to offer their products in these devices, which are rapidly becoming standard for injectable products.
"The Universe of Pre-filled Syringes and Injection Devices covers all aspects of advancements in drug delivery for injectables," said PDA President Richard Johnson. "The conference provides the latest information on new materials, drugs and application systems in the interest of public health and to the benefit of patients and health care providers."
The 2015 meeting sessions will address recent trends in development and manufacturing of pre-filled syringes, including patients' and the regulators' views, as well as regulatory and compliance trends for combination products/drug devices. The conference agenda is designed to encourage discussion amongst the scientific community, regulators and industry professionals.
More information on the event is available at https://www.pda.org/conference/2015-the-universe-of-pre-filled-syringes-and-injection-devices/home.
About PDA – Connecting People, Science and Regulation®
The Parenteral Drug Association (PDA) is the leading global provider of science, technology and regulatory information and education for the pharmaceutical and biopharmaceutical community. Founded in 1946 as a nonprofit organization, PDA is committed to developing scientifically sound, practical technical information and resources to advance science and regulation through the expertise of its 10,000 members worldwide. Go to http://www.pda.org/footer/about-pda to learn more.
Media Inquiries: Walt Morris, 301-656-5900, x. 148; [email protected]
Logo - http://photos.prnewswire.com/prnh/20130226/DC66667LOGO
SOURCE Parenteral Drug Association
Share this article